Michael David Alpert

Emmune, Inc

NIH Rank #3148
  • Early Career

NIH Funding · FY2024

Total Funding
$2.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#3,148
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.7M across 3 grants · National rank #3148.

Top grants by award amount

Michael David Alpert's NIH grant portfolio, ranked by award amount.

  • 5R44AI170392-03R44
    SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
    $1M
    award amount
  • 5R44AI165255-04R44
    Glycoengineering eCD4-Ig
    $974.7K
    award amount
  • 5U19AI149646-05U19
    An AAV-mediated functional cure and its impact on the reservoir
    $740.8K
    award amount

Affiliations

Institutions that have administered grants for Michael David Alpert.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Emmune, Inc
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3148
  6. 2024
    Entered Top 25% Nationally
    Ranked #3148
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Michael David Alpert.